Baird Medical (BDMD)
Makes microwave-ablation devices for liver and thyroid treatment.
$1.14
At close0.00 (0.00%)
In millions of USD, except per-share figures
| In millions | Q2 FY23Jun 2023 | Q4 FY23Dec 2023 | Q2 FY24Jun 2024 | Q4 FY24Dec 2024 | Q2 FY25Jun 2025 | Q4 FY25Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | 12 | 20 | 13 | 24 | 8 | 15 |
| Cost of revenue | 2 | 2 | 2 | 3 | 1 | 2 |
| Gross profit | 10 | 18 | 11 | 21 | 7 | 12 |
| 7 | 9 | 6 | 11 | 17 | 28 | |
| Research & development | 2 | 2 | 2 | 4 | 7 | 13 |
| 4 | 7 | 4 | 7 | 10 | 15 | |
| Selling & marketing | 2 | 1 | 1 | 3 | 1 | 0 |
| General & administrative | 2 | 6 | 3 | 4 | 9 | 0 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | 3 | 9 | 5 | 10 | −10 | −15 |
| 0 | 1 | 0 | −1 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | 3 | 9 | 5 | 9 | −11 | −16 |
| Income tax expense | 1 | 1 | 0 | 1 | 1 | 1 |
| Net income from continuing operations | 2 | 8 | 4 | 8 | −11 | −16 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 2 | 8 | 4 | 8 | −11 | −16 |
| EPS, basic | $0.08 | $0.38 | $0.58 | $0.38 | −$0.43 | −$0.55 |
| EPS, diluted | $0.08 | $0.38 | $0.58 | $0.38 | −$0.43 | −$0.55 |
| Weighted average shares, basic | 7 | 5 | 7 | 22 | 26 | 29 |
| Weighted average shares, diluted | 7 | 5 | 7 | 22 | 26 | 29 |
| EBITDA | 3 | 9 | 6 | 11 | −10 | −15 |
| Depreciation & amortization | 0 | 1 | 1 | 1 | 1 | 1 |
| EBIT | 3 | 9 | 5 | 10 | −10 | −15 |